PMC:7381711 / 2557-2743 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T13","span":{"begin":117,"end":124},"obj":"Body_part"}],"attributes":[{"id":"A13","pred":"fma_id","subj":"T13","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":" than prophylactic dosing) as an anticoagulant in COVID-19. We also discuss a subset of non-anticoagulant effects of heparin that may prove beneficial for the treatment of COVID-19. Fina"}

{"project":"LitCovid-PubTator","denotations":[{"id":"74","span":{"begin":117,"end":124},"obj":"Chemical"},{"id":"77","span":{"begin":50,"end":58},"obj":"Disease"},{"id":"78","span":{"begin":172,"end":180},"obj":"Disease"}],"attributes":[{"id":"A74","pred":"tao:has_database_id","subj":"74","obj":"MESH:D006493"},{"id":"A77","pred":"tao:has_database_id","subj":"77","obj":"MESH:C000657245"},{"id":"A78","pred":"tao:has_database_id","subj":"78","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" than prophylactic dosing) as an anticoagulant in COVID-19. We also discuss a subset of non-anticoagulant effects of heparin that may prove beneficial for the treatment of COVID-19. Fina"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T25","span":{"begin":50,"end":58},"obj":"Disease"},{"id":"T26","span":{"begin":172,"end":180},"obj":"Disease"}],"attributes":[{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" than prophylactic dosing) as an anticoagulant in COVID-19. We also discuss a subset of non-anticoagulant effects of heparin that may prove beneficial for the treatment of COVID-19. Fina"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T7","span":{"begin":76,"end":77},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" than prophylactic dosing) as an anticoagulant in COVID-19. We also discuss a subset of non-anticoagulant effects of heparin that may prove beneficial for the treatment of COVID-19. Fina"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T16","span":{"begin":33,"end":46},"obj":"Chemical"},{"id":"T17","span":{"begin":92,"end":105},"obj":"Chemical"},{"id":"T18","span":{"begin":117,"end":124},"obj":"Chemical"}],"attributes":[{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_50249"},{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_50249"},{"id":"A18","pred":"chebi_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"}],"text":" than prophylactic dosing) as an anticoagulant in COVID-19. We also discuss a subset of non-anticoagulant effects of heparin that may prove beneficial for the treatment of COVID-19. Fina"}

{"project":"LitCovid-sentences","denotations":[{"id":"T19","span":{"begin":60,"end":181},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" than prophylactic dosing) as an anticoagulant in COVID-19. We also discuss a subset of non-anticoagulant effects of heparin that may prove beneficial for the treatment of COVID-19. Fina"}